Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06624592 · ClinicalTrials.gov registry record · Phase 3
Sevoflurane/Dexmedetomidine vs. Isoflurane for Pediatric Emergence Delirium
A Phase 3 study of Delirium on Emergence, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT06624592: Recruiting Phase 3 study of Delirium on Emergence, sponsored by Mayo Clinic.
NCT06624592 is a Phase 3 study of Delirium on Emergence that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 400 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06624592, a Phase 3 study of Delirium on Emergence, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to measure the incidences of pediatric emergence delirium between the group receiving Isoflurane and the group receiving Sevoflurane plus intravenous push dexmedetomidine.
Primary Outcome
Total number of subjects with a Pediatric Anesthesia Emergence Delirium (PAED) score of \> 10. The PAED scale consists of 5 criteria that are scored using a 5-point scale. The scores of each criterion are added to make a total score. The maximum achievable total score is 20.
Conditions Studied
Interventions
- DRUG Sevoflurane
- DRUG Isoflurane
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2024-12-20 |
| Est. Completion | 2026-11-01 |
| Phase | Phase 3 |
What NCT06624592 shows while recruiting
NCT06624592 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (48% lower).
The record links to 1 condition, with Delirium on Emergence appearing as the primary indexed condition, and to 2 interventions - of which Sevoflurane is the first listed.
NCT06624592 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06624592 about?
NCT06624592 is a clinical study titled "Sevoflurane/Dexmedetomidine vs. Isoflurane for Pediatric Emergence Delirium". The purpose of this study is to measure the incidences of pediatric emergence delirium between the group receiving Isoflurane and the group receiving Sevoflurane plus intravenous push dexmedetomidine.
What is the current status of trial NCT06624592?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 400 participants. The study started on 2024-12-20. Estimated completion is 2026-11-01.
What conditions does trial NCT06624592 study?
This clinical trial studies the following conditions: Delirium on Emergence.
What interventions are being tested in trial NCT06624592?
The interventions under investigation include: Sevoflurane (DRUG), Isoflurane (DRUG).
Who is sponsoring clinical trial NCT06624592?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06624592 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06624592's enrollment target sits among peer trials
400 923rd of 2000 higher than 1,039 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI